Learning Objectives
At the conclusion of this activity, participants will be able to:
- Summarize evidence for first line systemic therapies for thymic carcinoma
- Review natural history and workup of thymic carcinoma
Session date:
01/29/2026 - 8:00am to 9:00am CST
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Hemanth Potluri, MD, PhD

Facebook
X
LinkedIn
Forward